Mirati e Merck focarão o estudo combinado de adagrasibe/Keytruda em pacientes com câncer de pulmão
December 06 2022 - 2:30PM
Newspaper
/jornal/2022/12/mirati-e-merck-focarao-o-estudo-combinado-de-adagrasibe-keytruda-em-pacientes-com-cancer-de-pulmao/
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From May 2024 to Jun 2024
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Mirati Therapeutics Inc (Brazil Bovespa Exchange): 0 recent articles
More News Articles